The powder material Gd 3 Ga 3 Al 2 O 12 :Ce (GGAG doped with Cerium) has garnered significant attention in radiation detection due to its high light yield and rapid decay time. Despite its potential, the synthesis of high-quality and reproducible GGAG:Ce scintillating powder remains a considerable challenge. In this study, we present a solvothermal approach with an annealing temperature of 1300 °C for producing cerium-doped GGAG powder with varying concentrations (4, 2, and 0.5 mol%). The structural and luminescent characteristics were meticulously examined using X-ray diffraction (XRD), field emission scanning electron microscopy (FESEM), photoluminescence (PL), radioluminescence (RL) spectroscopy, and X-ray photoelectron spectroscopy (XPS). XRD analysis confirmed the single-cubic phase garnet structure of the synthesized powder. By comparing the intermediate solvothermal products synthesized at different sintering temperatures (900 °C for 3 h and 1300 °C for 1 and 3 h), a direct correlation between solvothermal conditions and the structure/property relationships of the product was established. FESEM images revealed an ellipsoidal to irregular morphology of the as-synthesized GGAG:Ce microparticles, ranging from 0.1 to 0.3 μ m, regardless of the Ce concentration. PL spectra demonstrated a strong emission peak at approximately 550 nm, characteristic of Ce 3+ ions. RL data confirmed the peak luminescence at around 550 nm, with an almost twofold increase in intensity as the concentration of Ce 3+ increased from 0.5 mol% to 4 mol%. XPS data disclosed the Ce 3+ /Ce 4+ ratio in solvothermally synthesized GGAG:Ce, wherein Ce loading of 4 mol% demonstrated the increase in Ce 3+ concentration to 95%, whereas the concentration of Ce 4+ decreased to 5%. Notably, the highest luminescence efficiency was achieved with GGAG:Ce at a 4 mol% concentration. Thus, the solvothermal method employed in GGAG:Ce synthesis presents a straightforward approach, yielding rapid results with precise control over particle morphology and size.
No takes yet. Share an insight, caveat, or question.
Oad et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: